Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543363 | NSE Symbol : | ISIN : INE0GAO01018 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
27-Jan-2025	01-Feb-2025	Quarterly Results	Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2025 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter ended on December 31 2024. Considered and approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended on December 31, 2024. Intimation of Investment in Axiodent Inc. (As Per BSE Announcement Dated on: 01/02/2025)
04-Nov-2024	11-Nov-2024	Half Yearly Results	Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter and half year ended on September 30 2024. To consider and approve the unaudited financial results of the Company for the quarter and half year ended on September 30, 2024 (As Per BSE Announcement dated on 11.11.2024)
27-Sep-2024	27-Sep-2024	Change in Auditors	The Board of Directors at its meeting held on September 27, 2024 has approved the appointment of M/s. PAN & Associates as Cost Auditor of the Company for the F.Y. 2024-2025.
31-Jul-2024	08-Aug-2024	Final Dividend	Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve 1. To inter alia consider and approve the un-audited Financial Results of the Company (Standalone and Consolidated) for the quarter ended on June 30 2024. 2. To recommend the Final Dividend for the Financial Year 2023-24. 3.To consider and approve the date time mode and Draft of AGM Notice for holding 25th Annual General Meeting of the Company through video conferencing (VC) / Other Audio-Visual Mechanism (OAVM) The Board of directors approved the unaudited financial results (Standalone and consolidated) for the quarter ended June 30, 2024 and recommended final dividend. Recommendation of payment of Final Dividend on Equity Shares at the rate of 10% (Ten per cent) [i.e.,1.00/- (Rupees One Only) per Equity Share of Face Value of 10/- (Rupees Ten Only)] for the Financial Year ended March 31, 2024, subject to approval of shareholders at the ensuing Annual General Meeting. The dividend, if approved, shall be paid within the prescribed timeline. The Board of directors approved the unaudited financial results (Standalone and consolidated) for the quarter ended June 30, 2024 and recommended final dividend. (As Per BSE Announcement Dated on 08.08.2024)
03-May-2024	28-May-2024	Accounts	Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve the audited Financial Results of the Company for the quarter and year ended on March 31 2024. Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve the audited Financial Results of the Company for the quarter and year ended on March 31, 2024 We wish to inform you that the Meeting of the Board of Directors of Prevest Denpro Limited, originally scheduled for Friday, May 10, 2024, has been rescheduled. The new date for the meeting is now set for Tuesday, May 28, 2024. (As Per BSE Announcement Dated on 06/05/2024) Audited financial results of the Company for the quarter and financial year ended on March 31, 2024. (As Per BSE Announcement Dated on 28.05.2024)
24-Jan-2024	03-Feb-2024	Quarterly Results	Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter ended on December 31 2023. Considered and approved the un-audited financial results (Standalone and Consolidated) of the Company for the quarter ended on December 31, 2023. Considered and approved the un-audited financial results (standalone and consolidated) of the Company for the quarter ended on December 31, 2023. (As Per BSE Announcement Dated on 03/02/2024)
26-Oct-2023	03-Nov-2023	Half Yearly Results	Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter and half year ended on September 30 2023. Considered and approved the un-audited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended on September 30, 2023. (As Per BSE Announcement dated on 03.11.2023)
06-Sep-2023	01-Sep-2023	Change in Other Executives	Intimation of appointment of Mr. Aman Sadhotra as Company Secretary and Compliance Officer
27-Jul-2023	03-Aug-2023	Quarterly Results	Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2023 inter alia to consider and approve the un-audited Financial Results of the Company (Standalone and Consolidated) for the quarter ended on June 30 2023. To recommend the Final Dividend for the Financial Year 2022-23 To consider and approve the date time mode and Draft of AGM Notice for holding 24th Annual General Meeting of the Company through video conferencing (VC) / Other Audio-Visual Mechanism (OAVM) The Board of directors approved the unaudited financial results for the quarter ended June 30, 2023 and recommended final dividend Recommendation of payment of Final Dividend on Equity Shares at the rate of 10% (Ten per cent) [i.e.,1.00/- (Rupees One Only) per Equity Share of Face Value of 10/- (Rupees Ten Only)] for the Financial Year ended March 31, 2023., subject to approval of shareholders at the ensuing Annual General Meeting. The dividend, if approved, shall be paid within the prescribed timeline. Promoters have volunteered to waive dividend on their holdings on equity shares for the Financial Year 2022-23 The Board of directors approved the unaudited financial results for the quarter ended June 30, 2023 and recommended final dividend (As Per BSE Announcement PDF Dated on 03.08.2023)
19-Apr-2023	27-Apr-2023	Quarterly Results	Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2023 ,inter alia, to consider and approve the audited financial results for the quarter and year ended on 31st March 2023. Audited Results (As Per BSE Bulletin dated on 19.04.2023) The Board of Directors at its meeting held today i.e. on Thursday 27th April, 2023, has, inter-alia, considered, adopted and approved the Audited financial results of the Company for the quarter and year ended 31st March, 2023 and have taken on record the Auditors'''' Reports thereon. This is for your information and record Audited Financial Results Along With Audit Report Of The Auditor Of The Company For The Quarter And Financial Year Ended On March 31, 2023 (As per BSE Announcement Dated on 27/04/2023) Pursuant to the regulation 30 of SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015 (the 'Listing Regulations') read with Para A of Part A of Schedule III thereto and other applicable provisions of the Listing Regulations, we wish to inform you that the Board of Directors of the Company, at its meeting held on April 27, 2023, has approved the appointment of Mr. Pardeep Gandotra (DIN:08733719) as Additional Director (Independent) with immediate effect and Mr. Vaibhav Munjal (DIN:10072098) as an Additional Director (Executive Director) with immediate effect. Please note that the (As Per BSE Announcement Dated on 28/04/2023)
07-Feb-2023	13-Feb-2023	Quarterly Results	Quarterly Results Pursuant to the regulation 30 and 33 and other applicable regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., Monday, February 13, 2023 (commenced at 12:00 p.m. and concluded at 01.00 p.m.), inter-alia has the following: 1. Considered and approved the un-audited financial results of the Company for the quarter and nine months ended on December 31, 2022. 2. Considered and approved the Limited Review Report of the Auditors, in respect of the un-audited financial results of the Company for the quarter and nine months ended on December 31, 2022. (As Per BSE Announcement Dated on 13.02.2023)
03-Nov-2022	09-Nov-2022	Quarterly Results	Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve Pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 this is to inform you that a Meeting of the Board of Directors of the Company will be held on Wednesday November 09 2022 at 11:00 a.m. to interalia consider and approve the un-audited Financial Results of the Company for the quarter and half year ended on September 30 2022. Pursuant t0 the regulation 30 and 33 and other applicable regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., Wednesday, November 09, 2022 (commenced at 11:00 a.m. and concluded at 12:00 p.m.), inter-alia have the following: 1. Considered and approved the un-audited financial results of the Company for the quarter and half year ended on September 30, 2022. 2. Considered and approved the Limited Review Report of the Auditors, in respect of the un-audited financial results of the Company for the quarter and half year ended on September 30, 2022. Un-audited financial results along with Limited Review Report of the Auditor of the Company for the quarter and half year ended on September 30, 2022. (As Per BSE Announcement Dated on 09/11/2022)
28-Aug-2022	27-Aug-2022	Change in Other Executives	Pursuant to Regulation 30 of SEBI LODR 2015, we would like to inform you that on the recommendation of the Nomination & Remuneration Committee, the Board of Directors of the Company at their meeting held on Saturday, August 27, 2022, have approved the appointment of Ms. Krishna Rathi (ICSI Membership No. A64330) w.e.f. August 27, 2022 as the Company Secretary & Compliance Officer (Key Managerial Personnel) of the Company, pursuant to the provisions of Section 203 of the Companies Act, 2013 and Regulation 6(1) of SEBI LODR 2015. Kindly take the same on record for your further needful.
02-Aug-2022	10-Aug-2022	Quarterly Results	Quarterly Results Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 ,inter alia, to consider and approve Pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, this is to inform you that a Meeting of the Board of Directors of the Company will be held on Wednesday, August 10, 2022 at 11:00 a.m. to inter alia, consider and approve the un-audited Financial Results of the Company for the quarter ended on June 30, 2022. Please acknowledge and suitably disseminate to all concerned. This is to inform you that the Board of Directors of the Company at its meeting held on August 10, 2022 (commenced at 11:00 a.m. and concluded at 01.00 p.m.), inter-alia have the following: 1. Considered and approved the un-audited financial results of the Company for the quarter ended on June 30, 2022. 2. Considered and approved the Limited Review Report of the Auditors, in respect of the un-audited financial results of the Company for the quarter ended on June 30, 2022. 3. Considered and approved the Directors' Report along with Management Discussion and Analysis Report for the financial year ended March 31, 2022. 4. Considered and decided to hold the 23rd Annual General Meeting of the Members of the Company on Friday, September 16, 2022. 5. Considered and took note of the resignation of Ms. Komal Mehra from the post of Company Secretary and Compliance Officer of the Company with effect from the August 08, 2022 due to pre-occupancy in other assignments. (As Per BSE Announcement dated on 10.08.2022)
10-May-2022	17-May-2022	Half Yearly Results	Half Yearly Results & Audited Results Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2022 ,inter alia, to consider and approve Pursuant to the Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 17th May, 2022 at 01:00 p.m. at Registered office of the company, inter-alia, to approve the following business- 1. To consider, approve and take on record the Audited Financial Results and Auditor's Report of the Company for the Half Year and Financial year ended on 31st March, 2022. 2. Any other matter with the permission of the Chair. Further, as intimated earlier vide letter no. PREVEST/SE/2021-22/12 dated 31st March, 2022, this is to inform you that pursuant to the Company's code of conduct framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading Window for dealing in shares of the Company for persons specified under the Code, shall remain closed from Friday, 01st April, 2022 to Thursday, 19th May, 2022 (Both days inclusive). Pursuantto the Regulation 30 and 33 read with schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, we would like to inform you that the Board of Directors, at its meeting held on Tuesday, 17thMay, 2022, inter-alia approved 1) Audited Financial Results for the Half Yearand Yearended on 31st March, 2022along with Statement of Assets and Liabilities and Cash Flow Statement (Copy enclosed). 2) Auditor's Report on the Audited Financial Results for the Half Year and Year ended on 31st March, 2022 (Copy enclosed). (As Per BSE Announcement Dated on 17.05.2022) Pursuantto the Regulation 30 and 33 read with schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, we would like to inform you that the Board of Directors, at its meeting held on Tuesday, 17thMay, 2022, inter-alia approved 1) Audited Financial Results for the Half Year and Year ended on 31st March, 2022along with Statement of Assets and Liabilities and Cash Flow Statement (Copy enclosed). 2) Auditor's Report on the Audited Financial Results for the Half Year and Year ended on 31st March, 2022 (Copy enclosed). (As Per BSE Announcement dated on 18.05.2022)

1 2

LOGIN HERE

Prevest Denpro Ltd

Board Meeting